# Federal Realty Investment Trust: financial statements, quarterly

FRT · NYSE · CIK 34903 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frt.md) · [Financials](/companies/frt/financials.md) · [Filings](/companies/frt/filings.md) · [Insiders](/companies/frt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [281](/filings/0000034903-24-000056.md) | [287](/filings/0000034903-24-000069.md) | [292 d](/filings/0000034903-26-000017.md) | [291](/filings/0000034903-25-000037.md) | [296](/filings/0000034903-25-000052.md) | [304](/filings/0000034903-25-000063.md) | [311 d](/filings/0000034903-26-000017.md) | [309](/filings/0000034903-26-000026.md) | [312](/filings/0000034903-25-000052.md) | [322](/filings/0000034903-25-000063.md) | [336 d](/filings/0000034903-26-000017.md) | [341](/filings/0000034903-26-000026.md) |
| Operating income | $m | [102](/filings/0000034903-24-000056.md) | [100](/filings/0000034903-24-000069.md) | [109 d](/filings/0000034903-26-000017.md) | [100](/filings/0000034903-25-000037.md) | [157](/filings/0000034903-25-000052.md) | [106](/filings/0000034903-25-000063.md) | [109 d](/filings/0000034903-26-000017.md) | [108](/filings/0000034903-26-000026.md) | [203](/filings/0000034903-25-000052.md) | [111](/filings/0000034903-25-000063.md) | [181 d](/filings/0000034903-26-000017.md) | [209](/filings/0000034903-26-000026.md) |
| Interest expense | $m | [42.9](/filings/0000034903-24-000056.md) | [42.7](/filings/0000034903-24-000069.md) | [43.0 d](/filings/0000034903-26-000017.md) | [43.7](/filings/0000034903-25-000037.md) | [44.3](/filings/0000034903-25-000052.md) | [44.2](/filings/0000034903-25-000063.md) | [43.2 d](/filings/0000034903-26-000017.md) | [42.5](/filings/0000034903-26-000026.md) | [44.6](/filings/0000034903-25-000052.md) | [47.6](/filings/0000034903-25-000063.md) | [48.9 d](/filings/0000034903-26-000017.md) | [49.1](/filings/0000034903-26-000026.md) |
| Net income | $m | [60.5](/filings/0000034903-24-000056.md) | [57.0](/filings/0000034903-24-000069.md) | [64.1 d](/filings/0000034903-26-000017.md) | [56.7](/filings/0000034903-25-000037.md) | [112](/filings/0000034903-25-000052.md) | [61.0](/filings/0000034903-25-000063.md) | [65.5 d](/filings/0000034903-26-000017.md) | [63.8](/filings/0000034903-26-000026.md) | [156](/filings/0000034903-25-000052.md) | [61.6](/filings/0000034903-25-000063.md) | [130 d](/filings/0000034903-26-000017.md) | [159](/filings/0000034903-26-000026.md) |
| Diluted EPS | $ per share | [0.72](/filings/0000034903-24-000056.md) | [0.67](/filings/0000034903-24-000069.md) | not reported | [0.66](/filings/0000034903-25-000037.md) | [1.32](/filings/0000034903-25-000052.md) | [0.70](/filings/0000034903-25-000063.md) | not reported | [0.72](/filings/0000034903-26-000026.md) | [1.78](/filings/0000034903-25-000052.md) | [0.69](/filings/0000034903-25-000063.md) | not reported | [1.81](/filings/0000034903-26-000026.md) |
| Basic EPS | $ per share | [0.72](/filings/0000034903-24-000056.md) | [0.67](/filings/0000034903-24-000069.md) | not reported | [0.66](/filings/0000034903-25-000037.md) | [1.32](/filings/0000034903-25-000052.md) | [0.70](/filings/0000034903-25-000063.md) | not reported | [0.72](/filings/0000034903-26-000026.md) | [1.78](/filings/0000034903-25-000052.md) | [0.69](/filings/0000034903-25-000063.md) | not reported | [1.82](/filings/0000034903-26-000026.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [98.1](/filings/0000034903-23-000054.md) | [98.2](/filings/0000034903-23-000064.md) | [251](/filings/0000034903-25-000016.md) | [95.9](/filings/0000034903-24-000046.md) | [103](/filings/0000034903-24-000056.md) | [97.0](/filings/0000034903-24-000069.md) | [123](/filings/0000034903-26-000017.md) | [109](/filings/0000034903-25-000037.md) | [177](/filings/0000034903-25-000052.md) | [111](/filings/0000034903-25-000063.md) | [107](/filings/0000034903-26-000026.md) | [116](/filings/0000034903-26-000026.md) |
| Total assets | $m | [8,279](/filings/0000034903-23-000054.md) | [8,294](/filings/0000034903-23-000064.md) | [8,437](/filings/0000034903-25-000016.md) | [8,272](/filings/0000034903-24-000046.md) | [8,421](/filings/0000034903-24-000056.md) | [8,479](/filings/0000034903-24-000069.md) | [8,525](/filings/0000034903-26-000017.md) | [8,622](/filings/0000034903-25-000037.md) | [8,624](/filings/0000034903-25-000052.md) | [8,862](/filings/0000034903-25-000063.md) | [9,130](/filings/0000034903-26-000026.md) | [9,097](/filings/0000034903-26-000026.md) |
| Total liabilities | $m | [5,120](/filings/0000034903-23-000054.md) | [5,156](/filings/0000034903-23-000064.md) | [5,211](/filings/0000034903-25-000016.md) | [5,093](/filings/0000034903-24-000046.md) | [5,168](/filings/0000034903-24-000056.md) | [5,113](/filings/0000034903-24-000069.md) | [5,100](/filings/0000034903-26-000017.md) | [5,176](/filings/0000034903-25-000037.md) | [5,123](/filings/0000034903-25-000052.md) | [5,396](/filings/0000034903-25-000063.md) | [5,630](/filings/0000034903-26-000026.md) | [5,532](/filings/0000034903-26-000026.md) |
| Long-term debt | $m | not reported | not reported | [4,616](/filings/0000034903-24-000032.md) | not reported | not reported | not reported | [4,497](/filings/0000034903-25-000016.md) | not reported | not reported | not reported | [4,964](/filings/0000034903-26-000017.md) | not reported |
| Shareholders' equity | $m | [2,901](/filings/0000034903-23-000054.md) | [2,882](/filings/0000034903-23-000064.md) | [2,964](/filings/0000034903-25-000016.md) | [2,918](/filings/0000034903-24-000046.md) | [2,996](/filings/0000034903-24-000056.md) | [3,111](/filings/0000034903-24-000069.md) | [3,172](/filings/0000034903-26-000017.md) | [3,192](/filings/0000034903-25-000037.md) | [3,249](/filings/0000034903-25-000052.md) | [3,215](/filings/0000034903-25-000063.md) | [3,249](/filings/0000034903-26-000026.md) | [3,311](/filings/0000034903-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [149 d](/filings/0000034903-24-000056.md) | [151 d](/filings/0000034903-24-000069.md) | [113 d](/filings/0000034903-26-000017.md) | [141](/filings/0000034903-25-000037.md) | [170 d](/filings/0000034903-25-000052.md) | [144 d](/filings/0000034903-25-000063.md) | [120 d](/filings/0000034903-26-000017.md) | [179](/filings/0000034903-26-000026.md) | [151 d](/filings/0000034903-25-000052.md) | [148 d](/filings/0000034903-25-000063.md) | [145 d](/filings/0000034903-26-000017.md) | [185](/filings/0000034903-26-000026.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [79.2](/filings/0000034903-23-000054.md) | [81.5](/filings/0000034903-23-000064.md) | [81.1](/filings/0000034903-24-000046.md) | [81.2](/filings/0000034903-24-000056.md) | [81.3](/filings/0000034903-24-000069.md) | [82.6](/filings/0000034903-25-000037.md) | [83.6](/filings/0000034903-25-000052.md) | [84.0](/filings/0000034903-25-000063.md) | [85.5](/filings/0000034903-26-000026.md) | [86.6](/filings/0000034903-25-000052.md) | [86.0](/filings/0000034903-25-000063.md) | [86.7](/filings/0000034903-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 86,389,197 at 2026-04-28, from the cover of the [10-Q filed 2026-05-01](/filings/0000034903-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.